These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 32380286
1. Leishmaniavirus genetic diversity is not related to leishmaniasis treatment failure. Ginouvès M, Couppié P, Simon S, Bourreau E, Rogier S, Brousse P, Travers P, Pommier de Santi V, Demar M, Briolant S, Prévot G. Clin Microbiol Infect; 2021 Feb; 27(2):286.e1-286.e5. PubMed ID: 32380286 [Abstract] [Full Text] [Related]
5. Exacerbated Leishmaniasis Caused by a Viral Endosymbiont can be Prevented by Immunization with Its Viral Capsid. Castiglioni P, Hartley MA, Rossi M, Prevel F, Desponds C, Utzschneider DT, Eren RO, Zangger H, Brunner L, Collin N, Zehn D, Kuhlmann FM, Beverley SM, Fasel N, Ronet C. PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005240. PubMed ID: 28099431 [Abstract] [Full Text] [Related]
6. Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure. Christen JR, Bourreau E, Demar M, Lightburn E, Couppié P, Ginouvès M, Prévot G, Gangneux JP, Savini H, de Laval F, Pommier de Santi V, Briolant S. Travel Med Infect Dis; 2018 Jan; 24():31-36. PubMed ID: 29482012 [Abstract] [Full Text] [Related]
7. Further Evidence of an Association between the Presence of Leishmania RNA Virus 1 and the Mucosal Manifestations in Tegumentary Leishmaniasis Patients. Cantanhêde LM, da Silva Júnior CF, Ito MM, Felipin KP, Nicolete R, Salcedo JM, Porrozzi R, Cupolillo E, Ferreira Rde G. PLoS Negl Trop Dis; 2015 Jan; 9(9):e0004079. PubMed ID: 26372217 [Abstract] [Full Text] [Related]
11. Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia. Adaui V, Lye LF, Akopyants NS, Zimic M, Llanos-Cuentas A, Garcia L, Maes I, De Doncker S, Dobson DE, Arevalo J, Dujardin JC, Beverley SM. J Infect Dis; 2016 Jan 01; 213(1):112-21. PubMed ID: 26123565 [Abstract] [Full Text] [Related]
18. Detection of Leishmania RNA Virus in Clinical Samples from Cutaneous Leishmaniasis Patients Varies according to the Type of Sample. Parra-Muñoz M, Aponte S, Ovalle-Bracho C, Saavedra CH, Echeverry MC. Am J Trop Med Hyg; 2021 Jan 01; 104(1):233-239. PubMed ID: 33146111 [Abstract] [Full Text] [Related]
19. Concentration of 2'C-methyladenosine triphosphate by Leishmania guyanensis enables specific inhibition of Leishmania RNA virus 1 via its RNA polymerase. Robinson JI, Beverley SM. J Biol Chem; 2018 Apr 27; 293(17):6460-6469. PubMed ID: 29511088 [Abstract] [Full Text] [Related]
20. A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis. Neves LO, Talhari AC, Gadelha EP, Silva Júnior RM, Guerra JA, Ferreira LC, Talhari S. An Bras Dermatol; 2011 Apr 27; 86(6):1092-101. PubMed ID: 22281895 [Abstract] [Full Text] [Related] Page: [Next] [New Search]